Daniel K. Inouye College of Pharmacy (DKICP)

The following statement is for the Ph.D. in Pharmaceutical Sciences Program in the College of Pharmacy (CoP), which falls under the larger institution accreditation by the WASC Senior Commission. For more information on the quality assurance of the Pharm.D. program—which is accredited by the Accreditation Council for Pharmacy Education (ACPE) through June 30, 2025—please consult the accreditation homepage in the College of Pharmacy.

What does a Ph.D. from UH Hilo/CoP mean?

A Ph.D. in Pharmaceutical Sciences from the Daniel K. Inouye College of Pharmacy, University of Hawai‘i at Hilo symbolizes the culmination of research intensive study in the biomedical sciences related to the fundamental understanding of diseases, drug discovery and development, and healthcare. Our students exit having experienced first-hand the unique setting of the Big Island, which allows them to make use of our local biodiversity while undertaking innovative experiments that often have a direct impact on such areas as infectious disease, parasite control, and cancer research. The program is unique among other similar programs in the nation due to its focus and approach on natural products and their applications in health. This training nurtures and develops the next generation of scientists and leaders for the State of Hawai‘i and in the Asia-Pacific Region.


Program Last Review Next Review Current Self Study External Review Assessment
PH.D. Pharmaceutical Science 2010-2011

CoP PhD Program proposal 2010^

Temporarily suspended


CoP PhD Program Review 2020-2021^

CoP PhD  financial analysis(PDF)^


External Review  Consultant’s Report-2021

ALO Review of CoP Self Study 2020-2021

Dean’s Executive Review  of PhD Program 2020-2021

VCAA Review of CoP 2023


CoP SLOs, Curriculum Matrix, and Rubrics

Core Competency

Programmatic Assessment Data